GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 89 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104,705 | -27.7% | 60,875 | -18.1% | 0.03% | -24.4% |
| Q2 2023 | $144,875 | -58.9% | 74,295 | -41.4% | 0.04% | -61.7% |
| Q1 2023 | $352,248 | -21.0% | 126,708 | -2.0% | 0.11% | -28.7% |
| Q4 2022 | $446,044 | +30.8% | 129,288 | -2.7% | 0.15% | +23.0% |
| Q3 2022 | $341,000 | +6.2% | 132,851 | 0.0% | 0.12% | +10.9% |
| Q2 2022 | $321,000 | -54.1% | 132,851 | -21.7% | 0.11% | -43.3% |
| Q1 2022 | $699,000 | +104.4% | 169,736 | +538.6% | 0.19% | +123.0% |
| Q4 2021 | $342,000 | +19.6% | 26,580 | +0.2% | 0.09% | +13.0% |
| Q3 2021 | $286,000 | +18.2% | 26,524 | 0.0% | 0.08% | +18.5% |
| Q2 2021 | $242,000 | -9.7% | 26,524 | -3.2% | 0.06% | -13.3% |
| Q1 2021 | $268,000 | -2.5% | 27,413 | -60.7% | 0.08% | -12.8% |
| Q4 2020 | $275,000 | – | 69,778 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |